Piqray 150 mg

PIQRAY 150 MG tablets contain alpelisib, a medication used in cancer treatment. This oral tablet is manufactured by Novartis Pharmaceuticals Canada Inc. and is designed to target specific cancer cells.

PIQRAY 150 MG tablets are primarily used in the treatment of certain types of cancer. Alpelisib, the active ingredient, is often prescribed in combination with other therapies to target specific cancer cells. Patients may wonder, 'What is PIQRAY used for?' This medication is typically used in advanced or metastatic cancer cases where other treatments have not been effective.

Common effects of PIQRAY 150 MG tablets may include gastrointestinal issues, fatigue, and skin reactions. Some patients may experience changes in blood sugar levels or cholesterol. It is important to discuss any persistent or severe effects with a healthcare provider.

PIQRAY 150 MG tablets should be handled with care and stored as directed. Patients should follow their healthcare provider's instructions for administration and monitor for any adverse reactions. Pregnant women or those planning to become pregnant should consult their healthcare provider before using this medication.

PIQRAY 150 MG tablets may interact with certain medications, including those that affect liver enzymes. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare provider to avoid potential interactions.